We present a path towards single-source tumor documentation established at the Comprehensive Cancer Center Erlangen-Nürnberg (CCC-EN). Our goal was to derive data for cancer quality assurance and certification, cancer registry documentation and cancer research directly from routine care documentation. Therefore, clinical documentation activities were analyzed and a cancer data superset, containing these required elements, was developed. This superset was then split into appropriate clinical documentation packages, and the existing information technology infrastructure was analyzed and adapted to accommodate those documentation packages. A clinical documentation package is the amount of cancer-relevant data that can be captured within a clinical encounter. This grouping of data enables integration into existing clinical documentation workflows. We present examples in which single-source tumor documentation has been successfully established at the CCC-EN. The resulting cancer documentation reference model is described and its transferability to other institutions discussed.
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We present a path towards single-source tumor documentation established at the Comprehensive Cancer Center Erlangen-Nürnberg (CCC-EN). Our goal was to derive data for cancer quality assurance and certification, cancer registry documentation and cancer research directly from routine care documentation. Therefore, clinical documentation activities were analyzed and a cancer data superset, containing these required elements, was developed. This superset was then split into appropriate clinical documentation packages, and the existing information technology infrastructure was analyzed and adapted to accommodate those documentation packages. A clinical documentation package is the amount of cancer-relevant data that can be captured within a clinical encounter. This grouping of data enables integration into existing clinical documentation workflows. We present examples in which single-source tumor documentation has been successfully established at the CCC-EN. The resulting cancer documentation reference model is described and its transferability to other institutions discussed.
Introduction
Cancer is the cause of 12% of illness-related deaths worldwide [1] .AccordingtoEschenbachandBuetow,wearecurrentlyinthemidstofanexplosionofknowledgeaboutcancer asadiseaseprocess.Intheirvisionpaperfrom2006oncancer informatics [2] , they cite the US National Cancer Institute (NCI), which had challenged the oncology community to eliminatethesufferinganddeathduetocancerby2015,and admitthatitwillbeimpossibletoachievethisambitiousgoal without better interconnectivity and coordination across the cancerenterprise.TheauthorsproposedtheCancerBiomedicalInformaticsGrid(caBIG™)asaninteroperablebiomedical informatics infrastructure to overcome these obstacles. Oneoftheirkeyissuesfocusedon'Medicalorclinicalinformaticsenablingthemanagement,analysisanddissemination ofclinicalandpublichealthdata,includingtheuseofinformatics infrastructure and applications such as clinical trial management systems, electronic health records, and cancer registries'. However, the caBIG™ tools mainly provided support for cancer research, bioinformatics, and molecular research, and the close relationship between clinical care documentation, cancer registries and translational cancer researchreceivedlessattention [3] .Ontheotherhand,organizations such as the International Agency for Research on Cancer (IARC -WHO), the National Cancer Data Base (USA), the National Cancer Data Strategy (Australia) and the Working Group of German Tumor Centers (Germany) have emphasized the importance of cancer data registration andhavetriedtostandardizecancerregistrydocumentation [4] [5] [6] .Nationalcancerplansforoptimizedcarehavebeenset up [7] [8] [9] ,butoftenthisresultsinadditionalpaper-orinformation technology (IT)-based documentation efforts, e.g. for quality assurance, registry documentation and/or cancer research [10] . In Germany, the National Cancer Plan has identified the multitude of independent and uncoordinated documentation requirements as a major barrier for efficient cancerdocumentation.Theexistenceofparallelindependent documentationsystemsleadstoatremendousworkload,and thus hinders acceptance among physicians. Incompatible documentation systems overstrain hospitals and clinicians, andnon-comparabledatasetsalsoleadtovaryingresultsand inadequate conclusions. Thus, harmonization of normative regulations, the definition of 1 nationwide minimal cancer datasetandadata-sparinghomogeneouscancerdocumentation were fundamental recommendations within the crosssectionalfieldofactionfor'cancerdocumentation' [11] .
WhentheComprehensiveCancerCenterErlangen-Nuremberg (CCC-EN) was founded in 2008 as 1 of 11 oncology centers of excellence in Germany, those recommendations weredefinedasgeneralprinciplesofallITdevelopments,and acomprehensivesingle-sourceapproachfulfillingtherequirementsofcancercentercertification,cancerregistrydocumentation and cancer research, at the same time, was declared as our ultimate goal. We therefore developed a reference model for single-source tumor documentation, comprising a generic clinical documentation workflow and a cancer data superset. This superset was divided into clinical documentation packages in which every single documentation package couldbedocumentedattheclinicalencounter,i.e.wheresuch dataoriginate,andwithintherespectiveclinicalsystemthatis alreadyinroutineuseattherespectiveorganizationalunitof thehospital.WithintheoverallITinfrastructure,thedifferent systems were interfaced to provide data items for research purposes,and,inparticular,acompletecancerdatasuperset forthecancerregistrydatabase.
Methods
CurrentclinicaldocumentationprocessesatErlangenUniversityHospital were analyzed, and 13 medical specialty executives and 11 external cancerdocumentationexpertswereinterviewedusingasemi-structured interviewguidecoveringoncologycareprocesses,cancerregistration,IT supportandfutureuseofdata.Theseprocessesledtotheidentification ofclinicaldocumentationsteps,whichwerethenchronologicallyordered and assigned to organizational units and roles. We identified recurring documentation steps within the history of individual patients and the associationoftheserecurrenceswithparticulartypesofcare(e.g.hospital inpatient, hospital outpatient or ambulatory care). In addition, the currentmediumofdocumentation(e.g.paperorelectronic)andtherespective documentation system, if data were acquired electronically, were identified.
Wematchedthesedocumentationscenarioswithcancerdocumentationrequirementsfromtheviewpointofcancercentercertification,cancer quality assurance programs, and cancer research, as well as cancer registry documentation. The latter was defined as the joint set of basis tumordocumentationoftheWorkingGroupofGermanTumorcenters (AbeitsgemeinschaftDeutscherTumorzentren,ADT),thedatasetofthe SocietyofEpidemiologicalCancerRegistries(GesellschaftderepidemiologischenKrebsregisterinDeutschland,GEKID)andtheBavariancancer registrylaw(BCRL).Wealsoidentified16differentEuropeanandGer-man quality assurance and certification initiatives; within the CCC-EN context we focused on the German national quality insurance program and the 10 certificates of the German Cancer Association (Deutsche Krebsgesellschaft,DKG) [12] .
Withinahospital-wideinterdisciplinaryworkinggroupcomprisingIT staff,medicalstaffandmembersofthecancerregistry,wethusdefineda cancer data superset based on the analysis described above. Currently, however,althoughnospecificresearchdataelementshavebeenadded, we have confirmed that the cancer data superset meets basic requirements,e.g.forclinicaltrialsdocumentation,andhaveaddeddataitemsto document a patient's informed consent and assignment to clinical studies.
In this process we realized that, currently, none of the existing Germancancerdatasets(e.g.ADTorGEKID)meetsclinicaldocumentation reality.Althoughthedatasetsgroupdataelements,e.g.intoprimaryvisit dataorprimarytherapeuticprocedure,thesedataarenotcompletelyaccessible,e.g.inaprimaryvisit.ClinicalandpathologicalTNMstagingfor examplearedeterminedindifferentstepsduringpatientcare.Thelatter isonlyavailablewhenatissuesamplehasbeenexaminedinthepathology department and, at present, is documented in a freetext pathology report.However,bothitemsarerequiredfortheADTprimaryvisitdata.
SimilartotheapproachofAltmannetal. [13] ,wedividedthecancer datasupersetintoclinicaldocumentationpackagesaccordingtothepreviously identified clinical documentation workflow and the respective Ries/Prokosch/Beckmann/Bürkle clinicaleventforwhichthosedataaretypicallyrecorded.Inafinalstep, weassignedeachdocumentationpackagetotherespectivecomputerized information system at the CCC-EN and identified which IT interfaces neededtobeimplemented.
Results
The generic clinical documentation workflow, depicted in Figure1,illustratesthat4staffgroupsareinvolvedintumor documentation: administrative staff in admissions, medical stafffromdifferentmedicaldepartmentsatvariouspointsof time,staffofqualitymanagementresponsibleforcertification activities,andcancerregistrystaff.Thedocumentationworkflow starts with patient registration and administrative data documentation (1.1), which is followed by obtaining the patient'sinformedconsentfordatareuseinthecancerregistry andbiomaterialsstorage(1.2).Next,theclinicaldepartment responsible for the cancer entity (e.g. urology for prostate, bladder and renal cancer) collects anamnestic and initial assessment data (2.1), organizes the tumor conference (3.4), and,dependingonthetumorstaging,performssurgicalprocedures(4.1)(withtheexceptionofnon-solidtumorsorprimary radiooncology treatment) or organizes other therapeutic alternatives(e.g.immunotherapy)(4.4).Later,theresponsible clinical department organizes follow-up care (5.1). The pathology department (3.1), radiology department, nuclear medicine (3.2) and laboratory (3.3) are involved at various timesinthediagnosticandstagingprocess.Departmentsfor radiooncology(4.2)andoncology(4.3)areimportantprovidersfornon-surgicaltherapy.Cross-sectionalsupportivemeasuresareprovidedfromdepartmentssuchaspsycho-oncology, socialservicesandpalliativemedicineincludingpaintherapy (4.5-4.10).Inaddition,weincludeddatareuseforcancerresearch and biobanking, for quality assurance and for cancer registrypurposes.
The set of the data items required for or resulting from each documentation step comprised 286 data items, which were ordered into 20 clinical documentation packages (see fig. 2 ). A clinical documentation package is the amount of cancer-relevant data that can be captured within a certain clinical activity or encountered by 1 staff group and within 1 clinical documentation system (e.g. EMR (the electronic medical record), RIS (radiology information system), LIS (laboratoryinformationsystem),pathology(pathologydocumentationsystem),orsurgery(thesurgicaltheatredocumentation system)). We identified 3 different types of datasets: thosethatarerequiredonceonlyforeachpatient,suchaspatient administrative data; those that have to be documented foreachcancerentityofapatient(1patientmayhaveseveral canceroccurrencessimultaneouslyoratdifferenttimes);and thosethatarerequiredrepeatedly,e.g.diagnostics,treatments and follow-ups. Some of these documentation packages can alsobedocumentedinoutpatientorambulatorysettings.
Thecancerdatasupersetshouldbecapturedonlyonceat itsoriginandreusedwhereverneeded.Thesupersetisbased on the combined datasets of the ADT, GEKID and BCRL plus additional clinical data elements (see table 1 ). 161 elements(56%)comefromtheADTdataset.89%oftheADT elementshavebeenused,omittingforexampledatacollected fromautopsy.Interestingly,19%oftheGEKIDand24%of theBCRLdatasetelementsarenotpartoftheADT,promptingustoadd64elementsfromGEKIDand45fromBCRL formandatorycompletecoverageofthosedatasets.Noneof the German standard datasets included documentation of datafromsupportiveactivities,suchaspsycho-oncology,pain care or palliative care. Thus, to complete the cancer data superset, we added another 83 elements from those areas, which are mostly also required as indicators within cancer organ center certifications (e.g. as elements in the dotted documentationpackagesinFigure3).
The main goal of single-source tumor documentation is data reuse. Consequently, data should be captured in structured,numericordateformatforfurthercomputingpurposes. Ofthe286dataelements,83%fulfillthisrequirement;14% areunstructuredfreetextdataelementscontaining,forexample,nameoraddress,whichalsohadtobeaccepted.Tocrosscheck our cancer data superset with similar international activities, we performed an automated mapping of its data itemstotheNCIthesaurusandfoundappropriateNCIconceptsfor98%ofthe286dataelements.
Currently,astepwiseprocessisunderwaytoimplementall thosedocumentationitemswithintheITsystemsofErlangen UniversityHospital.FortheUrologyClinic(prostate,kidney andbladdercancerpatients)thecompletesetofclinicaldocumentationpackageshasalreadybeenimplemented,support- Single-sourceTumorDocumentation 139 registry.Thus,therespectiveclinicalITapplications(suchas the EMR, the surgery documentation system, and RIS) and non-clinicalITsystems(suchasthecancerregistrysystemor research databases) were interfaced to realize single-source documentation.Inourexampledatafromtheurologydepartment, such as the cancer diagnosis, ICD-O (International ClassificationofDiseaseforOncology)morphologycode,and theECOGandclinicalTNMclassificationarereusedwithina national biobanking project portal of the German Prostate Cancer Consortium [15, 16] , for the required quality indicatorsfortheGermanCancerAssociation(DKG)certification, andfortheErlangenCancerRegistrydatabase(seefig.3). Intotal,basedonthedescribedworkflowmodelandcancer data superset, we have implemented 12 different documentation scenarios at the CCC-EN so far. Our goal is a hospital-wide implementation of this concept for all cancer locations. ingtheroutineclinicalcaredocumentationdirectlywithinour IT systems. As an example, the left part of fig. 3 shows a screenshottakenfromanassessmentformfromtheurology department, showing parts of the clinical documentation package 2.1 anamnesis and initial assessment (see fig. 2 ). It contains the sections clinical tumor diagnosis, main localization, ECOG (Eastern Cooperative Oncology Group) life quality score and clinical TNM classification. All data elementsbelongtothecancerdatasuperset.Intheimplementationprocess,rigorousattentionwaspaidtodatabeingdocumentedonlyonceandbeingmadeelectronicallyavailablefor subsequent information retrieval and documentation purposes within the patient care process (e.g. as summarized medicalhistorydata-theelectroniccancerdiary [14] ,orfor semi-automated creation of discharge letters). However, it was important to also consider automated data reuse for cancer research, quality assurance programs and our cancer wholecancercareprocess' [11] .Inouropinion,however,the IT landscape in university hospitals is extremely heterogeneousandsubsetsofcancerdataarealreadydocumentedin various systems. Therefore, our approach concentrated on: defining an institution-wide cancer data superset (based on theGermandatasetsofADT,GEKIDandBCRL,enriched byadditionaldataelementstomeettherequirementsofGermanqualityassuranceinitiatives);mappingofsubsets(documentation packages) of this superset on particular clinical encounters and organizational units; the documentation of thoseitemswithinthealreadyavailableclinicalsystems,and thecomprehensiveintegrationofallsuchsystemswithcommunicationinterfaces.
Thisapproachcanpotentiallybeadaptedtoanyotherinstitutionby:(1)Analysisofclinicalworkflowsincancercare and development of an (optimized) clinical documentation workflow; (2) analysis of national cancer documentation requirements in detail with the goal of developing a detailed cancer data superset covering the essential requirements for cancercare,qualityassurance,cancerregistrationandcancer research; (3) grouping the data elements of this cancer data supersetintoclinicaldocumentationpackages,whichcanbe completedintherespectiveclinicalencounter;and(4)analysisoftheexistingITinfrastructure,definingappropriatedocumentationsystemsforeachclinicaldocumentationpackage, andimplementinganinterfaceinfrastructureforcooperative dataprocessing.
ThecancerdatasupersetpresentedinthispaperwasdevelopedbasedontheGermandatasetsoftheADT,GEKIDand BCRL,enrichedbyadditionaldataelementstomeettherequirementsofGermanqualityassuranceinitiatives.Inother countries this cancer data superset must be developed or adapted according to national requirements, such as the
Discussion
The lack of communication and information interchange betweensystems,thelackofsimplifiedstandardsandthelack ofimplementationandadherencetoavailablestandardswere recentlyidentifiedbyChahalasthemajorchallengesforestablishingefficientITinfrastructuresforcancerresearch [17] . Lau et al. [18] emphasized the value of EMR data for conducting epidemiological and outcome research, while Ochs andCasagrandein2008 [19] proposedanintegratedinformation architecture for comprehensive cancer centers and also stressed the need for methods to integrate research systems with other (clinical) enterprise systems. Although this problem has been partially addressed (e.g. in the NCI-founded caBIG™) [20] andtheNationalHealthService(NHS)-funded CancerGridinitiative [21] ,toourknowledgenosingle-source referencearchitecturebasedon1standardizeddatasetexists. Wecouldalsofindnopublicationsonacomprehensivecancer center IT implementation process in which such a singlesourceapproachhasbeenstrictlyfollowedtosupportclinical care, quality assurance, cancer registration and translational research. DevelopmentsliketheNCIthesauruscanbeseenasafirst step,buthavethelimitationthattheydonotsupplyadataset fortumordocumentation [22] ,butratherafullcollectionof potential data elements. The NCI thesaurus has never been mapped on real clinical processes to define which elements shouldbecapturedinwhichspecificclinicalencounter.
AlthoughmanyGermanpublicationsdescribethegoalto integrate single-source tumor documentation directly in the clinical care process [23] [24] [25] [26] [27] [28] , the recommendations of the GermanCancerPlanareoftenmisinterpretedas'theneedto establish1standardizedcancerdocumentationsystemforthe clinicaldataaredocumentedinhighquality [29] .Tothatend medicalstaffmustbemotivatedwithadditionalbenefits,such aspre-populatedphysicianletters,patientsummaries,orfollowupremindersdirectlywithinthepatientcareprocess,but alsowithpossibilityofreuseofsuchdatainresearchprojects.
